Breaking The Silence: How Medical Device Technology Powered by AI Can Make a Difference in Hypertension and Cardiovascular Risk Management
By Dinesh Kumar, Ph.D., Founder and CEO of Blend Health Technologies
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
By Dinesh Kumar, Ph.D., Founder and CEO of Blend Health Technologies
The financing significantly strengthens the company’s capital position as it expands U.S. commercial infrastructure and advances clinical evidence generation across its endovascular catheter platform.
Investments support seniors, people with disabilities, family caregivers, and the direct care workforce statewide
Peru joins the Latin American countries that already have this world-class innovation, used in international reference centers. In the country, institutions such as Clínica Delgado of the AUNA group will lead its implementation, consolidating Peru’s positioning at the forefront of electrophysiology
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
The global electrosurgical devices market is experiencing significant expansion, primarily fueled by the increasing incidence of chronic diseases, a growing number of surgical procedures, and the rising adoption of minimally invasive techniques that depend on accurate and controlled energy application. Ongoing advancements in electrosurgical technologies, such as enhanced safety mechanisms, better heat control, and advanced real-time monitoring systems, are also contributing to greater product uptake. Collectively, these developments are broadening clinical use, encouraging technological upgrades, and supporting the sustained growth of market demand